Harlow John B. Jr.insider trades

In SEC Form 4 filings, Harlow John B. Jr. is listed as President and COO of Larimar Therapeutics, Inc. (LRMR). Harlow John B. Jr. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 1.

Companies and roles

Company	Role	Transactions	Last filed
LRMRLarimar Therapeutics, Inc.	President and COO	2	Oct 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
LRMRLarimar Therapeutics, Inc.	Sep 29	Oct 1	A	50,000	$0.00	$0	50,000	No	Form 4
LRMRLarimar Therapeutics, Inc.	Sep 29	Oct 1	A · derivative	800,000	$3.14	$2,512,000	800,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.